Literature DB >> 25251899

Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.

S Sajeesh1, Tae Yeon Lee1, Joon Ki Kim1, Da Seul Son1, Sun Woo Hong1, Soohyun Kim2, Wan Soo Yun2, Soyoun Kim3, Chanil Chang4, Chiang Li5, Dong-ki Lee6.   

Abstract

RNA interference (RNAi) triggering oligonucleotides in unconventional structural format can offer advantages over conventional small interfering RNA (siRNA), enhanced cellular delivery and improved target gene silencing. With this concept, we present a well-defined tripodal-interfering RNA (tiRNA) structure that can induce simultaneous silencing of multiple target genes with improved potency. The tiRNA structure, formed by the complementary association of three single-stranded RNA units, was optimized for improved gene silencing efficacy. When combined with cationic polymers such as linear polyethyleneimine (PEI), tiRNA assembled to form a stable nano-structured complex through electrostatic interactions and induced stronger RNAi response over conventional siRNA-PEI complex. In combination with a liver-targeting delivery system, tripodal nucleic acid structure demonstrated enhanced fluorescent accumulation in mouse liver compared to standard duplex nucleic acid format. Tripodal RNA structure complexed with galactose-modified PEI could generate effective RNAi-mediated gene silencing effect on experimental mice models. Our studies demonstrate that optimized tiRNA structural format with appropriate polymeric carriers have immense potential to become an RNAi-based platform suitable for multi-target gene silencing.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liver targeting; Nanoparticles; Polyethyleneimine; RNA interference; Tripodal-interfering RNA (tiRNA)

Mesh:

Substances:

Year:  2014        PMID: 25251899     DOI: 10.1016/j.jconrel.2014.09.016

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

Review 1.  Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.

Authors:  Rossella Farra; Mario Grassi; Gabriele Grassi; Barbara Dapas
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

2.  Design, synthesis and evaluation of novel, branched trident small interfering RNA nanostructures for sequence-specific RNAi activity.

Authors:  Akash Chandela; Yoshihito Ueno
Journal:  RSC Adv       Date:  2019-10-23       Impact factor: 4.036

3.  Co-transfection of decorin and interleukin-10 modulates pro-fibrotic extracellular matrix gene expression in human tenocyte culture.

Authors:  Sunny A Abbah; Dilip Thomas; Shane Browne; Timothy O'Brien; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

4.  Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis.

Authors:  Lu Diao; Jin Tao; Yiqi Wang; Ying Hu; Wenfei He
Journal:  Int J Nanomedicine       Date:  2019-11-04

5.  Chimeric Flaviviral RNA-siRNA Molecules Resist Degradation by The Exoribonuclease Xrn1 and Trigger Gene Silencing in Mammalian Cells.

Authors:  Cressida Harvey; Sven Klassa; Esteban Finol; Jonathan Hall; Alyssa C Hill
Journal:  Chembiochem       Date:  2021-09-12       Impact factor: 3.164

6.  Chemically Synthesized, Self-Assembling Small Interfering RNA-Prohead RNA Molecules Trigger Dicer-Independent Gene Silencing.

Authors:  Alyssa C Hill; Daniël van Leeuwen; Verena Schlösser; Alok Behera; Bogdan Mateescu; Jonathan Hall
Journal:  Chemistry       Date:  2022-01-12       Impact factor: 5.020

7.  Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection.

Authors:  E Crouchet; R Saad; C Affolter-Zbaraszczuk; J Ogier; T F Baumert; C Schuster; F Meyer
Journal:  J Mater Chem B       Date:  2017-01-09       Impact factor: 7.571

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.